1 Market Overview of β2 Adrenoceptor Agonists 1.1 β2 Adrenoceptor Agonists Market Overview 1.1.1 β2 Adrenoceptor Agonists Product Scope 1.1.2 β2 Adrenoceptor Agonists Market Status and Outlook 1.2 Global β2 Adrenoceptor Agonists Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global β2 Adrenoceptor Agonists Market Size by Region (2016-2027) 1.4 Global β2 Adrenoceptor Agonists Historic Market Size by Region (2016-2021) 1.5 Global β2 Adrenoceptor Agonists Market Size Forecast by Region (2022-2027) 1.6 Key Regions, β2 Adrenoceptor Agonists Market Size (2016-2027) 1.6.1 North America β2 Adrenoceptor Agonists Market Size (2016-2027) 1.6.2 Europe β2 Adrenoceptor Agonists Market Size (2016-2027) 1.6.3 Asia-Pacific β2 Adrenoceptor Agonists Market Size (2016-2027) 1.6.4 Latin America β2 Adrenoceptor Agonists Market Size (2016-2027) 1.6.5 Middle East & Africa β2 Adrenoceptor Agonists Market Size (2016-2027) 2 β2 Adrenoceptor Agonists Market Overview by Type 2.1 Global β2 Adrenoceptor Agonists Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global β2 Adrenoceptor Agonists Historic Market Size by Type (2016-2021) 2.3 Global β2 Adrenoceptor Agonists Forecasted Market Size by Type (2022-2027) 2.4 Albuterol 2.5 Terbutaline 2.6 Salmeterol 2.7 Formoterol 2.8 Pirbuterol 3 β2 Adrenoceptor Agonists Market Overview by Application 3.1 Global β2 Adrenoceptor Agonists Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global β2 Adrenoceptor Agonists Historic Market Size by Application (2016-2021) 3.3 Global β2 Adrenoceptor Agonists Forecasted Market Size by Application (2022-2027) 3.4 Bronchial Asthma 3.5 Asthmatic Bronchitis 3.6 Emphysema 3.7 Others 4 β2 Adrenoceptor Agonists Competition Analysis by Players 4.1 Global β2 Adrenoceptor Agonists Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in β2 Adrenoceptor Agonists as of 2020) 4.3 Date of Key Players Enter into β2 Adrenoceptor Agonists Market 4.4 Global Top Players β2 Adrenoceptor Agonists Headquarters and Area Served 4.5 Key Players β2 Adrenoceptor Agonists Product Solution and Service 4.6 Competitive Status 4.6.1 β2 Adrenoceptor Agonists Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Ivax Pharmaceuticals  5.1.1 Ivax Pharmaceuticals  Profile 5.1.2 Ivax Pharmaceuticals  Main Business 5.1.3 Ivax Pharmaceuticals  β2 Adrenoceptor Agonists Products, Services and Solutions 5.1.4 Ivax Pharmaceuticals  β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.1.5 Ivax Pharmaceuticals  Recent Developments 5.2 Physicians Total Care 5.2.1 Physicians Total Care Profile 5.2.2 Physicians Total Care Main Business 5.2.3 Physicians Total Care β2 Adrenoceptor Agonists Products, Services and Solutions 5.2.4 Physicians Total Care β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.2.5 Physicians Total Care Recent Developments 5.3 Baxter Healthcare  5.5.1 Baxter Healthcare  Profile 5.3.2 Baxter Healthcare  Main Business 5.3.3 Baxter Healthcare  β2 Adrenoceptor Agonists Products, Services and Solutions 5.3.4 Baxter Healthcare  β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.3.5 Sanofi Recent Developments 5.4 Sanofi 5.4.1 Sanofi Profile 5.4.2 Sanofi Main Business 5.4.3 Sanofi β2 Adrenoceptor Agonists Products, Services and Solutions 5.4.4 Sanofi β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.4.5 Sanofi Recent Developments 5.5 Pfizer 5.5.1 Pfizer Profile 5.5.2 Pfizer Main Business 5.5.3 Pfizer β2 Adrenoceptor Agonists Products, Services and Solutions 5.5.4 Pfizer β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.5.5 Pfizer Recent Developments 5.6 Bedford Laboratories 5.6.1 Bedford Laboratories Profile 5.6.2 Bedford Laboratories Main Business 5.6.3 Bedford Laboratories β2 Adrenoceptor Agonists Products, Services and Solutions 5.6.4 Bedford Laboratories β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.6.5 Bedford Laboratories Recent Developments 5.7 Novartis 5.7.1 Novartis Profile 5.7.2 Novartis Main Business 5.7.3 Novartis β2 Adrenoceptor Agonists Products, Services and Solutions 5.7.4 Novartis β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.7.5 Novartis Recent Developments 5.8 Sterimax 5.8.1 Sterimax Profile 5.8.2 Sterimax Main Business 5.8.3 Sterimax β2 Adrenoceptor Agonists Products, Services and Solutions 5.8.4 Sterimax β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.8.5 Sterimax Recent Developments 5.9 Teligent 5.9.1 Teligent Profile 5.9.2 Teligent Main Business 5.9.3 Teligent β2 Adrenoceptor Agonists Products, Services and Solutions 5.9.4 Teligent β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.9.5 Teligent Recent Developments 5.10 AstraZeneca 5.10.1 AstraZeneca Profile 5.10.2 AstraZeneca Main Business 5.10.3 AstraZeneca β2 Adrenoceptor Agonists Products, Services and Solutions 5.10.4 AstraZeneca β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.10.5 AstraZeneca Recent Developments 5.11 Hikma Pharmaceuticals 5.11.1 Hikma Pharmaceuticals Profile 5.11.2 Hikma Pharmaceuticals Main Business 5.11.3 Hikma Pharmaceuticals β2 Adrenoceptor Agonists Products, Services and Solutions 5.11.4 Hikma Pharmaceuticals β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.11.5 Hikma Pharmaceuticals Recent Developments 5.12 Av Kare 5.12.1 Av Kare Profile 5.12.2 Av Kare Main Business 5.12.3 Av Kare β2 Adrenoceptor Agonists Products, Services and Solutions 5.12.4 Av Kare β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.12.5 Av Kare Recent Developments 5.13 Impax Laboratories 5.13.1 Impax Laboratories Profile 5.13.2 Impax Laboratories Main Business 5.13.3 Impax Laboratories β2 Adrenoceptor Agonists Products, Services and Solutions 5.13.4 Impax Laboratories β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.13.5 Impax Laboratories Recent Developments 5.14 PD-Rx Pharmaceuticals 5.14.1 PD-Rx Pharmaceuticals Profile 5.14.2 PD-Rx Pharmaceuticals Main Business 5.14.3 PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Products, Services and Solutions 5.14.4 PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.14.5 PD-Rx Pharmaceuticals Recent Developments 5.15 Athenex Pharmaceutical Division 5.15.1 Athenex Pharmaceutical Division Profile 5.15.2 Athenex Pharmaceutical Division Main Business 5.15.3 Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Products, Services and Solutions 5.15.4 Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.15.5 Athenex Pharmaceutical Division Recent Developments 5.16 Teva 5.16.1 Teva Profile 5.16.2 Teva Main Business 5.16.3 Teva β2 Adrenoceptor Agonists Products, Services and Solutions 5.16.4 Teva β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.16.5 Teva Recent Developments 5.17 Marlex Pharmaceuticals 5.17.1 Marlex Pharmaceuticals Profile 5.17.2 Marlex Pharmaceuticals Main Business 5.17.3 Marlex Pharmaceuticals β2 Adrenoceptor Agonists Products, Services and Solutions 5.17.4 Marlex Pharmaceuticals β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.17.5 Marlex Pharmaceuticals Recent Developments 5.18 Lannett Company 5.18.1 Lannett Company Profile 5.18.2 Lannett Company Main Business 5.18.3 Lannett Company β2 Adrenoceptor Agonists Products, Services and Solutions 5.18.4 Lannett Company β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.18.5 Lannett Company Recent Developments 5.19 West-Ward Pharmaceuticals 5.19.1 West-Ward Pharmaceuticals Profile 5.19.2 West-Ward Pharmaceuticals Main Business 5.19.3 West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Products, Services and Solutions 5.19.4 West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.19.5 West-Ward Pharmaceuticals Recent Developments 5.20 United Biomedical 5.20.1 United Biomedical Profile 5.20.2 United Biomedical Main Business 5.20.3 United Biomedical β2 Adrenoceptor Agonists Products, Services and Solutions 5.20.4 United Biomedical β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.20.5 United Biomedical Recent Developments 5.21 Merck 5.21.1 Merck Profile 5.21.2 Merck Main Business 5.21.3 Merck β2 Adrenoceptor Agonists Products, Services and Solutions 5.21.4 Merck β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.21.5 Merck Recent Developments 5.22 Mylan 5.22.1 Mylan Profile 5.22.2 Mylan Main Business 5.22.3 Mylan β2 Adrenoceptor Agonists Products, Services and Solutions 5.22.4 Mylan β2 Adrenoceptor Agonists Revenue (US$ Million) & (2016-2021) 5.22.5 Mylan Recent Developments 6 North America 6.1 North America β2 Adrenoceptor Agonists Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe β2 Adrenoceptor Agonists Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific β2 Adrenoceptor Agonists Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America β2 Adrenoceptor Agonists Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa β2 Adrenoceptor Agonists Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 β2 Adrenoceptor Agonists Market Dynamics 11.1 β2 Adrenoceptor Agonists Industry Trends 11.2 β2 Adrenoceptor Agonists Market Drivers 11.3 β2 Adrenoceptor Agonists Market Challenges 11.4 β2 Adrenoceptor Agonists Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market β2 Adrenoceptor Agonists Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global β2 Adrenoceptor Agonists Market Size by Region (2016-2021) & (US$ Million) Table 3. Global β2 Adrenoceptor Agonists Market Size Share by Region (2016-2021) Table 4. Global β2 Adrenoceptor Agonists Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global β2 Adrenoceptor Agonists Forecasted Market Size Share by Region (2022-2027) Table 6. Global β2 Adrenoceptor Agonists Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global β2 Adrenoceptor Agonists Market Size by Type (2016-2021) & (US$ Million) Table 8. Global β2 Adrenoceptor Agonists Revenue Market Share by Type (2016-2021) Table 9. Global β2 Adrenoceptor Agonists Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global β2 Adrenoceptor Agonists Revenue Market Share by Type (2022-2027) Table 11. Global β2 Adrenoceptor Agonists Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global β2 Adrenoceptor Agonists Market Size by Application (2016-2021) & (US$ Million) Table 13. Global β2 Adrenoceptor Agonists Revenue Market Share by Application (2016-2021) Table 14. Global β2 Adrenoceptor Agonists Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global β2 Adrenoceptor Agonists Revenue Market Share by Application (2022-2027) Table 16. Global β2 Adrenoceptor Agonists Revenue (US$ Million) by Players (2016-2021) Table 17. Global β2 Adrenoceptor Agonists Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in β2 Adrenoceptor Agonists as of 2020) Table 19. Date of Key Manufacturers Enter into β2 Adrenoceptor Agonists Market Table 20. Global β2 Adrenoceptor Agonists Top Players Headquarters and Area Served Table 21. β2 Adrenoceptor Agonists Product Solution and Service Table 22. Global β2 Adrenoceptor Agonists Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Ivax Pharmaceuticals  Basic Information List Table 25. Ivax Pharmaceuticals  Description and Business Overview Table 26. Ivax Pharmaceuticals  β2 Adrenoceptor Agonists Products, Services and Solutions Table 27. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Ivax Pharmaceuticals  (2016-2021) Table 28. Ivax Pharmaceuticals  Recent Developments Table 29. Physicians Total Care Basic Information List Table 30. Physicians Total Care Description and Business Overview Table 31. Physicians Total Care β2 Adrenoceptor Agonists Products, Services and Solutions Table 32. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Physicians Total Care (2016-2021) Table 33. Physicians Total Care Recent Developments Table 34. Baxter Healthcare  Basic Information List Table 35. Baxter Healthcare  Description and Business Overview Table 36. Baxter Healthcare  β2 Adrenoceptor Agonists Products, Services and Solutions Table 37. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Baxter Healthcare  (2016-2021) Table 38. Baxter Healthcare  Recent Developments Table 39. Sanofi Basic Information List Table 40. Sanofi Description and Business Overview Table 41. Sanofi β2 Adrenoceptor Agonists Products, Services and Solutions Table 42. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Sanofi (2016-2021) Table 43. Sanofi Recent Developments Table 44. Pfizer Basic Information List Table 45. Pfizer Description and Business Overview Table 46. Pfizer β2 Adrenoceptor Agonists Products, Services and Solutions Table 47. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Pfizer (2016-2021) Table 48. Pfizer Recent Developments Table 49. Bedford Laboratories Basic Information List Table 50. Bedford Laboratories Description and Business Overview Table 51. Bedford Laboratories β2 Adrenoceptor Agonists Products, Services and Solutions Table 52. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Bedford Laboratories (2016-2021) Table 53. Bedford Laboratories Recent Developments Table 54. Novartis Basic Information List Table 55. Novartis Description and Business Overview Table 56. Novartis β2 Adrenoceptor Agonists Products, Services and Solutions Table 57. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Novartis (2016-2021) Table 58. Novartis Recent Developments Table 59. Sterimax Basic Information List Table 60. Sterimax Description and Business Overview Table 61. Sterimax β2 Adrenoceptor Agonists Products, Services and Solutions Table 62. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Sterimax (2016-2021) Table 63. Sterimax Recent Developments Table 64. Teligent Basic Information List Table 65. Teligent Description and Business Overview Table 66. Teligent β2 Adrenoceptor Agonists Products, Services and Solutions Table 67. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Teligent (2016-2021) Table 68. Teligent Recent Developments Table 69. AstraZeneca Basic Information List Table 70. AstraZeneca Description and Business Overview Table 71. AstraZeneca β2 Adrenoceptor Agonists Products, Services and Solutions Table 72. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of AstraZeneca (2016-2021) Table 73. AstraZeneca Recent Developments Table 74. Hikma Pharmaceuticals Basic Information List Table 75. Hikma Pharmaceuticals Description and Business Overview Table 76. Hikma Pharmaceuticals β2 Adrenoceptor Agonists Products, Services and Solutions Table 77. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Hikma Pharmaceuticals (2016-2021) Table 78. Hikma Pharmaceuticals Recent Developments Table 79. Av Kare Basic Information List Table 80. Av Kare Description and Business Overview Table 81. Av Kare β2 Adrenoceptor Agonists Products, Services and Solutions Table 82. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Av Kare (2016-2021) Table 83. Av Kare Recent Developments Table 84. Impax Laboratories Basic Information List Table 85. Impax Laboratories Description and Business Overview Table 86. Impax Laboratories β2 Adrenoceptor Agonists Products, Services and Solutions Table 87. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Impax Laboratories (2016-2021) Table 88. Impax Laboratories Recent Developments Table 89. PD-Rx Pharmaceuticals Basic Information List Table 90. PD-Rx Pharmaceuticals Description and Business Overview Table 91. PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Products, Services and Solutions Table 92. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of PD-Rx Pharmaceuticals (2016-2021) Table 93. PD-Rx Pharmaceuticals Recent Developments Table 94. Athenex Pharmaceutical Division Basic Information List Table 95. Athenex Pharmaceutical Division Description and Business Overview Table 96. Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Products, Services and Solutions Table 97. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Athenex Pharmaceutical Division (2016-2021) Table 98. Athenex Pharmaceutical Division Recent Developments Table 99. Teva Basic Information List Table 100. Teva Description and Business Overview Table 101. Teva β2 Adrenoceptor Agonists Products, Services and Solutions Table 102. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Teva (2016-2021) Table 103. Teva Recent Developments Table 104. Marlex Pharmaceuticals Basic Information List Table 105. Marlex Pharmaceuticals Description and Business Overview Table 106. Marlex Pharmaceuticals β2 Adrenoceptor Agonists Products, Services and Solutions Table 107. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Marlex Pharmaceuticals (2016-2021) Table 108. Marlex Pharmaceuticals Recent Developments Table 109. Lannett Company Basic Information List Table 110. Lannett Company Description and Business Overview Table 111. Lannett Company β2 Adrenoceptor Agonists Products, Services and Solutions Table 112. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Lannett Company (2016-2021) Table 113. Lannett Company Recent Developments Table 114. West-Ward Pharmaceuticals Basic Information List Table 115. West-Ward Pharmaceuticals Description and Business Overview Table 116. West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Products, Services and Solutions Table 117. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of West-Ward Pharmaceuticals (2016-2021) Table 118. West-Ward Pharmaceuticals Recent Developments Table 119. United Biomedical Basic Information List Table 120. United Biomedical Description and Business Overview Table 121. United Biomedical β2 Adrenoceptor Agonists Products, Services and Solutions Table 122. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of United Biomedical (2016-2021) Table 123. United Biomedical Recent Developments Table 124. Merck Basic Information List Table 125. Merck Description and Business Overview Table 126. Merck β2 Adrenoceptor Agonists Products, Services and Solutions Table 127. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Merck (2016-2021) Table 128. Merck Recent Developments Table 129. Mylan Basic Information List Table 130. Mylan Description and Business Overview Table 131. Mylan β2 Adrenoceptor Agonists Products, Services and Solutions Table 132. Revenue (US$ Million) in β2 Adrenoceptor Agonists Business of Mylan (2016-2021) Table 133. Mylan Recent Developments Table 134. North America β2 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million) Table 135. North America β2 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) Table 136. Europe β2 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million) Table 137. Europe β2 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) Table 138. Asia-Pacific β2 Adrenoceptor Agonists Market Size by Region (2016-2021) & (US$ Million) Table 139. Asia-Pacific β2 Adrenoceptor Agonists Market Size by Region (2022-2027) & (US$ Million) Table 140. Asia-Pacific β2 Adrenoceptor Agonists Market Share by Region (2016-2021) Table 141. Asia-Pacific β2 Adrenoceptor Agonists Market Share by Region (2022-2027) Table 142. Latin America β2 Adrenoceptor Agonists Market Size by Country (2016-2021) & (US$ Million) Table 143. Latin America β2 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) Table 144. Middle East & Africa β2 Adrenoceptor Agonists Market Size by Players (2016-2021) & (US$ Million) Table 145. Middle East & Africa β2 Adrenoceptor Agonists Market Size by Country (2022-2027) & (US$ Million) Table 146. β2 Adrenoceptor Agonists Market Trends Table 147. β2 Adrenoceptor Agonists Market Drivers Table 148. β2 Adrenoceptor Agonists Market Challenges Table 149. β2 Adrenoceptor Agonists Market Restraints Table 150. Research Programs/Design for This Report Table 151. Key Data Information from Secondary Sources Table 152. Key Data Information from Primary Sources List of Figures Figure 1. Global β2 Adrenoceptor Agonists Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global β2 Adrenoceptor Agonists Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global β2 Adrenoceptor Agonists Market Share by Regions: 2021 VS 2027 Figure 4. Global β2 Adrenoceptor Agonists Forecasted Market Size Share by Region (2022-2027) Figure 5. North America β2 Adrenoceptor Agonists Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe β2 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific β2 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America β2 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa β2 Adrenoceptor Agonists Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global β2 Adrenoceptor Agonists Market Size Share by Type in 2021 & 2027 Figure 11. Albuterol Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Terbutaline Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Salmeterol Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Formoterol Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Pirbuterol Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Global β2 Adrenoceptor Agonists Market Size Share by Application in 2021 & 2027 Figure 17. Bronchial Asthma Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Asthmatic Bronchitis Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Emphysema Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 21. β2 Adrenoceptor Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Top 5 and Top 10 Players β2 Adrenoceptor Agonists Market Share in 2020 Figure 23. North America β2 Adrenoceptor Agonists Market Share by Country (2016-2027) Figure 24. United States β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 25. Canada β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 26. Germany β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 27. France β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 28. U.K. β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 29. Italy β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 30. Russia β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 31. Nordic β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 32. Rest of Europe β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 33. Asia-Pacific β2 Adrenoceptor Agonists Market Share by Region (2016-2027) Figure 34. China β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 35. Japan β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 36. South Korea β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 37. Southeast Asia β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 38. India β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 39. Australia β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 40. Rest of Asia-Pacific β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 41. Latin America β2 Adrenoceptor Agonists Market Share by Country (2016-2027) Figure 42. Mexico β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 43. Brazil β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 44. Rest of Latin America β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 45. Middle East & Africa β2 Adrenoceptor Agonists Market Share by Country (2016-2027) Figure 46. Turkey β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 47. Saudi Arabia β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 48. UAE β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 49. Rest of Middle East & Africa β2 Adrenoceptor Agonists Market Size (2016-2027) & (US$ Million) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation

Ivax Pharmaceuticals  Physicians Total Care Baxter Healthcare  Sanofi Pfizer Bedford Laboratories Novartis Sterimax Teligent AstraZeneca Hikma Pharmaceuticals Av Kare Impax Laboratories PD-Rx Pharmaceuticals Athenex Pharmaceutical Division Teva Marlex Pharmaceuticals Lannett Company West-Ward Pharmaceuticals United Biomedical Merck Mylan